FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
NCT00625404
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2120
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Truvada
OTHER:
Placebo
Sponsor
FHI 360